Literature DB >> 2684258

True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis.

C A Hanson1, W Jaszcz, J H Kersey, M G Astorga, B A Peterson, K J Gajl-Peczalska, G Frizzera.   

Abstract

Five cases of true histiocytic lymphoma (THL) were analysed by immunophenotyping and immunoglobulin/T-cell receptor genotyping. These cases showed striking morphologic diversity but a strong degree of immunophenotypic homogeneity. The malignant cells reacted with multiple histiocytic markers including CD11c (Ki-M1, LeuM5), CD14, CD68 (Ki-M6) and Ki-M8; anti-HLA-DR and non-specific esterase staining was also found in all cases. The malignant cells did not express monoclonal immunoglobulin and did not react with the B- or T-cell monoclonal antibodies used except for those known to be cytoplasmically expressed in monocytes/histiocytes, such as CD4 and CD19; B- and T-cell staining was otherwise limited to background small lymphocytes. By genotypic analysis, three cases showed rearrangements: one with T beta, one with T beta and immunoglobulin heavy chain (JH) and one with both JH and light chain; the remaining two cases retained their immunoglobulin and T-cell receptor genes in germline configuration. The results not only suggest that certain subsets of the histiocyte/reticulum cell system may be capable of rearranging immunoglobulin or T beta genes while simultaneously expressing multiple histiocytic surface antigens but also demonstrate the necessity of using multiple histiocytic-specific monoclonal antibodies and cytochemical staining in diagnosing THL. Gene rearrangement studies must be interpreted in conjunction with immunophenotyping and morphology in the determination of cell lineage.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684258     DOI: 10.1111/j.1365-2141.1989.tb00251.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin.

Authors:  S S Banerjee; J Heald; M Harris
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 2.  The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions.

Authors:  Zhenqiang Gao; Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2005-09-28       Impact factor: 2.199

3.  PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.

Authors:  B Falini; L Flenghi; S Pileri; M Gambacorta; B Bigerna; H Durkop; F Eitelbach; J Thiele; R Pacini; A Cavaliere
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

4.  Comprehensive genomic characterization of five canine lymphoid tumor cell lines.

Authors:  Sarah C Roode; Daniel Rotroff; Kristy L Richards; Peter Moore; Alison Motsinger-Reif; Yasuhiko Okamura; Takuya Mizuno; Hajime Tsujimoto; Steven E Suter; Matthew Breen
Journal:  BMC Vet Res       Date:  2016-09-17       Impact factor: 2.741

5.  Hematopoietic neoplasms in Prkar2a-deficient mice.

Authors:  Emmanouil Saloustros; Paraskevi Salpea; Chen-Feng Qi; Lina A Gugliotti; Kitman Tsang; Sisi Liu; Matthew F Starost; Herbert C Morse; Constantine A Stratakis
Journal:  J Exp Clin Cancer Res       Date:  2015-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.